Pablo E. Monserrate, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: G1 Calle San Mateo, Urb. Alturas De San Pedro, Fajardo, PR 00738 Phone: 787-738-7499 |
Johan Vargas, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 404 Ave General Valero, Fajardo, PR 00738 Phone: 787-655-0505 |
Jean-luc Charlot, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 404 Ave General Valero, Fajardo, PR 00738 Phone: 787-655-0505 |
Dr. Sonia Enid Ortiz Flores, M.D. Family Medicine - Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 410 Ave General Valero, Suite 504, Fajardo, PR 00738 Phone: 787-863-7100 Fax: 787-863-1114 |
News Archive
Adult stem cells may help repair heart tissue damaged by heart attack according to the findings of a new study to be published in the December 8 issue of the Journal of the American College of Cardiology. Results from the Phase I study show stem cells from donor bone marrow appear to help heart attack patients recover better by growing new blood vessels to bring more oxygen to the heart
University of Virginia Health System and Novant Health are in discussions to create a Northern Virginia regional health system. The proposed agreement would include UVA Culpeper Hospital and all of Novant Health's Virginia facilities, including Novant Health Haymarket Medical Center, Novant Health Prince William Medical Center and Novant Health Cancer Center.
Facing incurable breast cancer at age 55, MaryAnne DiCanto put her faith in "precision medicine" — in which doctors try to match patients with drugs that target the genetic mutations in their tumors. She underwent repeated biopsies to identify therapies that might help.
The Spinal Muscular Atrophy Foundation and Rules-Based Medicine, announced today that they have reached the first milestone in a program to develop a panel of plasma protein biomarkers for SMA using RBM's Multi-Analyte Profiling technology platform.
Bausch + Lomb, the global eye health company, and Mimetogen Pharmaceuticals Inc. today announced that Bausch + Lomb has acquired an option to license an investigational compound currently in Phase 2 development for the treatment of dry eye syndrome, a condition that affects millions of people worldwide.
› Verified 7 days ago